Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: a post-hoc analysis of the DANFLU-1 trial by Lassen, MCH, Johansen, ND, Modin, D, Nealon, J, Samson, S, Dufournet, M, Loiacono, MM, Larsen, CS, Jensen, AMR, Landler, NE, Claggett, BL, Solomon, SD, Landray, MJ, Gislason, GH, Køber, L, Jensen, JUS, Sivapalan, P, Vestergaard, LS, Krause, TG, Biering-Sørensen, T

Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: a post-hoc analysis of the DANFLU-1 randomized clin... by Christensen, J, Johansen, ND, Janstrup, KH, Modin, D, Skaaru, KG, Nealon, J, Samson, S, Loiacono, M, Harris, R, Larsen, CS, Jensen, AMR, Landler, NE, Claggett, BL, Solomon, SD, Gislason, GH, Køber, L, Landray, MJ, Sivapalan, P, Jensen, JUS, Biering-Sørensen, T

A pragmatic randomized feasibility trial of influenza vaccines by Johansen, ND, Modin, D, Nealon, J, Samson, S, Salamand, C, Loiacono, MM, Larsen, CS, Jensen, AMR, Landler, NE, Claggett, BL, Solomon, SD, Landray, MJ, Gislason, GH, Køber, L, Jensen, JUS, Sivapalan, P, Vestergaard, LS, Valentiner-Branth, P, Krause, TG, Biering-Sørensen, T

Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: a post-hoc ana... by Johansen, ND, Modin, D, Skaarup, KG, Nealon, J, Samson, S, Dufournet, M, Loiacono, MM, Harris, RC, Larsen, CS, Jensen, AMR, Landler, NE, Claggett, BL, Solomon, SD, Landray, MJ, Gislason, GH, Køber, L, Jensen, JUS, Sivapalan, P, Vestergaard, LS, Valentiner-Branth, P, Krause, TG, Biering-Sørensen, T

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an... by Wechalekar, A, Antoni, G, Al Azzam, W, Bergström, M, Biswas, S, Chen, C, Cheriyan, J, Cleveland, M, Cookson, L, Galette, P, Janiczek, RL, Kwong, RY, Lukas, MA, Millns, H, Richards, D, Schneider, I, Solomon, SD, Sörensen, J, Storey, J, Thompson, D, van Dongen, G, Vugts, DJ, Wall, A, Wikström, G, Falk, RH

Sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes: a SMART-C collaborative meta-analysis by Patel, SM, Kang, YM, Im, K, Neuen, BL, Anker, SD, Bhatt, DL, Butler, J, Cherney, DZI, Claggett, BL, Fletcher, RA, Herrington, WG, Inzucchi, SE, Jardine, MJ, Mahaffey, KW, McGuire, DK, McMurray, JJV, Neal, B, Packer, M, Perkovic, V, Solomon, SD, Staplin, N, Vaduganathan, M, Wanner, C, Wheeler, DC, Zannad, F, Zhao, Y, Heerspink, HJL, Sabatine, MS, Wiviott, SD

2017 cardiovascular and stroke endpoint definitions for clinical trials by Hicks, KA, Mahaffey, KW, Mehran, R, Nissen, SE, Wiviott, SD, Dunn, B, Solomon, SD, Marler, JR, Teerlink, JR, Farb, A, Morrow, DA, Targum, SL, Sila, CA, Hai, MT, Jaff, MR, Joffe, HV, Cutlip, DE, Desai, AS, Lewis, EF, Gibson, CM, Landray, MJ, Lincoff, AM, White, CJ, Brooks, SS, Rosenfield, K, Domanski, MJ, Lansky, AJ, McMurray, JJV, Tcheng, JE, Steinhubl, SR, Burton, P, Mauri, L, O'Connor, CM, Pfeffer, MA, Hung, HMJ, Stockbridge, NL, Chaitman, BR, Temple, RJ

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials by Hicks, KA, Mahaffey, KW, Mehran, R, Nissen, SE, Wiviott, SD, Dunn, B, Solomon, SD, Marler, JR, Teerlink, JR, Farb, A, Morrow, DA, Targum, SL, Sila, CA, Hai, MTT, Jaff, MR, Joffe, HV, Cutlip, DE, Desai, AS, Lewis, EF, Gibson, CM, Landray, MJ, Lincoff, AM, White, CJ, Brooks, SS, Rosenfield, K, Domanski, MJ, Lansky, AJ, McMurray, JJV, Tcheng, JE, Steinhubl, SR, Burton, P, Mauri, L, O'Connor, CM, Pfeffer, MA, Hung, HMJ, Stockbridge, NL, Chaitman, BR, Temple, RJ, Standardized Data Collection For Cardiovascular Trials Initiative (Scti)